Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?

Heart Rhythm

Volumn 3, Issue 4, 2006, Pages 484-487

  Eckardt, Lars ^a   Breithardt, Günter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; SODIUM CHANNEL BLOCKING AGENT;

BRADYCARDIA; CLINICAL STUDY; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; DRUG EFFICACY; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART PACING; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIVER TOXICITY; LONG TERM CARE; LUNG TOXICITY; MORTALITY; NEUROTOXICITY; PATIENT COMPLIANCE; PHOTOSENSITIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SKIN DISCOLORATION; SLEEP DISORDER; SURVIVAL RATE; TREMOR; VISUAL DISORDER;

EID: 33645875871     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2005.11.010     Document Type: Article

References (21)

1. M. Mirowski P.R. Reid M.M. Mower L. Watkins V.L. Gott J.F. Schauble A. Langer M.S. Heilman S.A. Kolenik R.E. Fischell M.L. Weisfeldt Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings N Engl J Med 303 1980 322-324
2. Amiodarone Trials Meta-Analysis Investigators Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials Lancet 350 1997 1417-1424
3. F. Boutitie J.P. Boissel S.J. Connolly A.J. Camm J.A. Cairns D.G. Julian M. Gent M.J. Janse P. Dorian G. Frangin The EMIAT and CAMIAT Investigators Amiodarone interaction with beta-blockers analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases Circulation 99 1999 2268-2275
4. S.J. Connolly A.P. Hallstrom R. Cappato E.B. Schron K.H. Kuck D.P. Zipes H.L. Greene S. Boczor M. Domanski D. Follmann M. Gent R.S. Roberts Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 2000 2071-2078
5. R. Sheldon S. Connolly A. Krahn R. Roberts M. Gent M. Gardner Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy the Canadian Implantable Defibrillator Study Circulation 101 2000 1660-1664
6. S.A. Strickberger J.D. Hummel T.G. Bartlett H.I. Frumin C.D. Schuger S.L. Beau C. Bitar F. Morady Amiodarone versus implantable cardioverter-defibrillator randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT J Am Coll Cardiol 41 2003 1707-1712
7. G.H. Bardy K.L. Lee D.B. Mark J.E. Poole D.L. Packer R. Boineau M. Domanski C. Troutman J. Anderson G. Johnson S.E. McNulty N. Clapp-Channing L.D. Davidson-Ray E.S. Fraulo D.P. Fishbein R.M. Luceri J.H. Ip Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225-237
8. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576-1583
9. K.H. Kuck R. Cappato J. Siebels R. Ruppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748-754
10. S.J. Connolly M. Gent R.S. Roberts P. Dorian D. Roy R.S. Sheldon L.B. Mitchell M.S. Green G.J. Klein B. O'Brien Canadian implantable defibrillator study (CIDS) a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 2000 1297-1302
11. B.M. Massie S.G. Fisher P.C. Deedwania B.N. Singh R.D. Fletcher S.N. Singh Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure Circulation 93 1996 2128-2134
12. A.J. Moss W.J. Hall D.S. Cannom J.P. Daubert S.L. Higgins H. Klein J.H. Levine S. Saksena A.L. Waldo D. Wilber M.W. Brown M. Heo Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia N Engl J Med 335 1996 1933-1940
13. A.J. Moss Implantable cardioverter defibrillator therapy in sickest patients benefit the most Circulation 101 2000 1638-1640
14. A.J. Moss Y. Fadl W. Zareba D.S. Cannom W.J. Hall Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease Am J Cardiol 88 2001 516-520
15. D. Bänsch D. Böcker J. Brunn M. Weber G. Breithardt M. Block Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators J Am Coll Cardiol 36 2000 566-573
16. D. Bänsch M. Antz S. Boczor M. Volkmer J. Tebbenjohanns K. Seidl M. Block F. Gietzen J. Berger K.H. Kuck Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy trial (CAT) Circulation 105 2002 1453-1458
17. J.A. Cairns S.J. Connolly J. Roberts M. Gent Randomised trial after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators Lancet 349 1997 675-682
18. F. Bokhari D. Newman M. Greene V. Korley I. Mangat P. Dorian Long-term comparison of the implantable cardioverter defibrillator versus amiodarone eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS) Circulation 110 2004 112-116
19. H.C. Doval D.R. Nul H.O. Grancelli S.V. Perrone G.R. Bortman R. Curiel Grupo de Estudio de la Sobrevida en la Insufficiencia Cardiaca en Argentina (GESICA) Randomised trial of low-dose amiodarone in severe congestive heart failure Lancet 344 1994 493-498
20. S.N. Singh R.D. Fletcher S. Gross Fischer B.N. Singh H.D. Lewis P.C. Deedwania B.M. Massie C. Colling D. Lazzeri Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia N Engl J Med 333 1995 77-82
21. D.G. Julian A.J. Camm G. Frangin M.J. Janse A. Munoz P.J. Schwartz P. Simon European Myocardial Infarct Amiodarone Trial Investigators Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction Lancet 349 1997 667-674